Beam Therapeutics (BEAM) Interest Coverage Ratio (QoQ) (2019 - 2025)
Beam Therapeutics (BEAM) Interest Coverage Ratio (QoQ) (2019 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Beam Therapeutics | 2.68 Bn | 2.68 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -322.17% |
| Jun 30, 2025 | -122.76% |
| Mar 31, 2025 | -25,769.27% |
| Dec 31, 2024 | 99.99% |
| Sep 30, 2024 | -8,124.25% |
| Jun 30, 2024 | -165.51% |
| Mar 31, 2024 | -4,223.22% |
| Dec 31, 2023 | 102.65% |
| Sep 30, 2023 | -169.77% |
| Jun 30, 2023 | 84.81% |
| Mar 31, 2023 | 53.58% |
| Dec 31, 2022 | -5,802.81% |
| Sep 30, 2022 | -2,230.26% |
| Jun 30, 2022 | 77.59% |
| Mar 31, 2022 | 73.62% |
| Dec 31, 2021 | 36.77% |
| Sep 30, 2021 | 10.81% |
| Jun 30, 2021 | 78.53% |
| Mar 31, 2021 | 59.49% |
| Dec 31, 2020 | -1,483.95% |